Paper415987
Inhibition of allergic reactions by cromoglycate and by a new antiallergy drug U-42,585E. II. Activity in primates against aerosolized Ascaris suum antigen.
Johnson HG and 2 others. Int Arch Allergy Appl Immunol, 1978. Cited by 25 papers, by iCite.
11 sourcespapers-2026-11-12-0.1.0
Cite this record
ConductScience Library. Inhibition of allergic reactions by cromoglycate and by a new antiallergy drug U-42,585E. II. Activity in primates against aerosolized Ascaris suum antigen. Papers, record 415987. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/415987
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Inhibition of allergic reactions by cromoglycate and by a new antiallergy drug U-42,585E. II. Activity in primates against aerosolized Ascaris suum antigen.
- PubMed
Topics11
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Antigens | Major topic |
| Ascaris | Major topic |
| Cromolyn Sodium | Major topic |
| Hypersensitivity | Major topic |
| Administration, Intranasal | |
| Animals | |
| Dose-Response Relationship, Immunologic | |
| Female | |
| Haplorhini | |
| Respiratory Function Tests | |
| Time Factors |
Source PubMed
Cited by6
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 25 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 6,652,969 | Ascaris-induced bronchoconstriction in primates experimentally infected with Ascaris suum ova. | Clin Exp Immunol | 1983 | https://conductscience.org/library/papers/6652969 | PubMed |
| 6,136,101 | Inhalation challenge with specific grass pollen antigens in asthmatics and the effect of lodoxamide tromethamine. | Thorax | 1983 | https://conductscience.org/library/papers/6136101 | PubMed |
| 6,121,476 | Inhibition of oxidative enzymes by anti-allergy drugs. | Agents Actions | 1981 | https://conductscience.org/library/papers/6121476 | PubMed |
| 3,092,596 | Alternative modes of action of sodium cromoglycate. | Agents Actions | 1986 | https://conductscience.org/library/papers/3092596 | PubMed |
| 2,875,630 | The characterization of lodoxamide, a very active inhibitor of mediator release, in animal and human models of asthma. | Agents Actions | 1986 | https://conductscience.org/library/papers/2875630 | PubMed |
| 115,253 | The effect of lodoxamide ethyl [diethyl N,N'-(2-chloro-5-cyano-m-phenylene)dioxamate] on in vivo anaphylactic reactions. | Agents Actions | 1979 | https://conductscience.org/library/papers/115253 | PubMed |
Genes1
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes |
|---|---|---|---|
| IGHE | 3,497 | PubTator's text mining | https://conductscience.org/library/genes/3497 |
Source NCBI Gene
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/415987
GET https://conductscience.org/api/papers/v1/415987/authors